(Congenit Heart Dis[TA])
1,425 results
  • Collaborating to Improve Outcomes in Congenital Heart Disease: The Pediatric Heart Network Experience. [Journal Article]
    Congenit Heart Dis. 2025; 20(6):637-646.Schwartz BN, Pemberton VL, … Pearson GDCH
  • CONCLUSIONS: The PHN's success is due to fostering collaboration across pediatric cardiology centers, creating a clinical research infrastructure that can adapt to different types of studies, and emphasizing career development of young investigators and research coordinators. This paper will summarize the PHN's history, partnerships, use of clinical registries, future directions, and ways to get involved.
  • Alterations in Metabolites Associated with Hypoxemia in Neonates and Infants with Congenital Heart Disease. [Journal Article]
    Congenit Heart Dis. 2020 Sep 07; 15(4):251-265.Pagano E, Frank B, … Davidson JCH
  • CONCLUSIONS: We did not find evidence supporting global metabolic changes associated with cyanotic congenital heart disease in neonates or older infants. However, specific metabolites did discriminate between hypoxemic and non-hypoxemic neonates. These include methylmalonic acid, as well as several metabolites known to change in hypoxia-reoxygenation states (hypoxanthine) and chronic hypoxemic states (glutamate, thymine, myo-inositol) and may represent specific metabolic changes triggered by hypoxemia among neonates with cyanotic congenital heart disease.